# EDGAR Filing Document

**Accession Number:** 0001423221
**File Stem:** 0001171843-23-001554
**Filing Date:** 2023-3
**Character Count:** 36670
**Document Hash:** 14849510cd14025a75076cf549763d80
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001171843-23-001554.hdr.sgml**: 20230309

**ACCESSION NUMBER**: 0001171843-23-001554

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230309

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230309

**DATE AS OF CHANGE**: 20230309

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Quanex Building Products CORP
- **CENTRAL INDEX KEY:** 0001423221
- **STANDARD INDUSTRIAL CLASSIFICATION:** ROLLING DRAWING & EXTRUDING OF NONFERROUS METALS [3350]
- **IRS NUMBER:** 261561397
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33913
- **FILM NUMBER:** 23719969

**BUSINESS ADDRESS:**
- **STREET 1:** 1800 WEST LOOP SOUTH
- **STREET 2:** SUITE 1500
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77027
- **BUSINESS PHONE:** 7139614600

**MAIL ADDRESS:**
- **STREET 1:** 1800 WEST LOOP SOUTH
- **STREET 2:** SUITE 1500
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77027

?xml version="1.0" encoding="utf-8"?Form 8-K

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

### Washington, D.C. 20549
_________________

### FORM 8-K
_________________

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported): March 9, 2023
_______________________________

#### Quanex Building Products Corporation
(Exact name of registrant as specified in its charter)

_______________________________

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-33913** | **26-1561397** |
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |

---

#### 1800 West Loop South, Suite 1500

#### Houston, Texas 77027
(Address of Principal Executive Offices) (Zip Code)

(713) 961-4600

(Registrant's telephone number, including area code)

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $0.01 per share | NX | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 2.02. Results of Operations and Financial Condition.**

On March 9, 2023, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

**Item 9.01. Financial Statements and Exhibits.**

<br> [99.1](exh_991.htm) [Press Release dated March 9, 2023](exh_991.htm) <br> 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Quanex Building Products Corporation** | **Quanex Building Products Corporation** |
| Date: March 9, 2023 | By: | <u>/s/ SCOTT ZUEHLKE&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> |
|  |  | Scott Zuehlke |
|  |  | SVP, CFO and Treasurer |

---

## Exhibit 99.1

**EXHIBIT 99.1**

**Quanex Building Products Announces First Quarter 2023 Results and Provides Full Year 2023 Guidance**

**Balance Sheet and Liquidity Remain Strong Significant Improvement in Cash Provided by Operating Activities Revenue Growth in NA and EU Fenestration Segments, Excluding FX Impact Integration of LMI Custom Mixing Assets on Track Cautiously Optimistic on Second Half of 2023 Positive Long-Term View on Residential Housing Market Remains Intact**

HOUSTON, March 09, 2023 (GLOBE NEWSWIRE) -- **<u>Quanex Building Products Corporation</u>** (NYSE:NX) ("Quanex" or the "Company") today announced its results for the three months ended January 31, 2023.

The Company reported the following selected financial results:

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended January 31,** | **Three Months Ended January 31,** |
| ($ in millions, except per share data) | **2023** | **2022** |
| Net Sales | $261.9 | $267.0 |
| Gross Margin | $51.8 | $55.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Gross Margin %* | *19.8%* | *20.7%* |
| Net Income | $1.9 | $11.2 |
| Diluted EPS | $0.06 | $0.34 |
| Adjusted Net Income | $6.1 | $11.3 |
| Adjusted Diluted EPS | $0.18 | $0.34 |
| Adjusted EBITDA | $20.5 | $24.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Adjusted EBITDA Margin %* | *7.8%* | *9.1%* |
| Cash Provided by (Used For) Operating Activities | $3.1 | ($21.7 |
| Free Cash Flow | ($4.4) | ($29.0) |

---

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, President and Chief Executive Officer, stated, "Our results for the first quarter of 2023 were generally as expected with the only caveat being an elevated level of customer inventory re-balancing initiatives in our fenestration segments. We believe we are seeing a return to what is normal seasonality in our business. In addition to lower market demand year-over-year, results for the quarter were impacted by higher stock-based compensation expense from the increase in our stock price, one-time transaction and advisory fees, increased interest expense related to rising rates on the debt we incurred to fund the acquisition of LMI Custom Mixing, LLC ("LMI"), and foreign exchange translation. While results in our legacy North American Fenestration segment were impacted by market volume declines and customer inventory rebalancing initiatives, the LMI business performed well and controllable operational performance in the legacy business continues to be strong. Results in our North American Cabinet Components segment were impacted by index related price decreases and soft market demand; however, margins were consistent compared to the same period of last year. Our European Fenestration business performed well despite additional macroeconomic headwinds, including the war in Ukraine and increased energy costs. In fact, after adjusting for the foreign exchange translation impact, we generated revenue growth in Europe and margins held up nicely. As we look ahead, it is important to note that while pricing for raw materials and related surcharges are declining, inflationary pressures still exist in many areas. We are focused on making sure our product pricing takes all factors into account.

"Notwithstanding some near-term macroeconomic challenges, our balance sheet remains strong even after accounting for the debt we borrowed to fund the acquisition of LMI. The integration of LMI is going well, and we have already started realizing synergies. Despite the overall softness compared to the same period of 2022, we were still able to pay down some debt towards the end of the first quarter and our leverage remains low."

**First Quarter 2023 Results Summary**

The Company reported net sales of $261.9 million during the three months ended January 31, 2023, which represents a decrease of 1.9% compared to $267.0 million for the same period of 2022. The decrease was mostly attributable to softer demand, customer inventory rebalancing initiatives and foreign exchange translation impact. Quanex realized net sales growth of 4.3% for the first quarter of 2023 in its North American Fenestration segment, which was driven by the contribution from LMI. Excluding LMI, net sales in the North American Fenestration segment would have declined by approximately 7% year-over-year. The Company reported a decline in net sales of 12.3% in its North American Cabinet Components segment and an increase of 3.9% in net sales in its European Fenestration segment, excluding foreign exchange impact. (See Sales Analysis table for additional information)

The decrease in earnings for the three months ended January 31, 2023 was largely due to lower volumes, one-time transaction and advisory fees, foreign exchange translation, higher interest expense and increased stock-based compensation expense, mostly due to stock price appreciation.

**Balance Sheet & Liquidity Update**

As of January 31, 2023, the Company had total debt of $155.1 million ($100.0 million excluding real-estate leases that are considered "finance" leases under U.S. GAAP) and Quanex's leverage ratio of Net Debt to LTM Adjusted EBITDA was 0.8x (0.4x excluding these real-estate leases). As previously disclosed, the Company borrowed $92 million to acquire substantially all the assets of LMI on November 1, 2022. As of January 31, 2023, the Company's LTM Adjusted EBITDA was $148.6 million and LTM Net Income, the most directly comparable GAAP measure, was $79.0 million. (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

Quanex's liquidity was $263.0 million as of January 31, 2023, consisting of $43.0 million in cash on hand plus availability under its Amended and Restated Senior Secured Revolving Credit Facility due 2027, less letters of credit outstanding.

**Outlook**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Mr. Wilson commented, "While the near-term outlook for our business remains somewhat cautious, our long-term view has not changed, and we believe the underlying fundamentals for the residential housing market remain positive. Considering these strong market fundamentals, and our belief that we have returned to a more normalized seasonality pattern, we are cautiously optimistic that demand will improve in the second half of our fiscal year. That said, we are also proactively working to adjust our cost structure to protect margins in the event that second half improvement doesn't materialize as currently expected. Overall, on a consolidated basis, and assuming fundamentals do not worsen materially, we estimate we will generate net sales of $1.12 billion to $1.16 billion, which we expect will yield approximately $130 million to $142 million in Adjusted EBITDA\* in fiscal 2023.

As always, we will stay focused on the things we can control. Our capital allocation priorities are generating cash, paying down debt, evaluating growth opportunities and opportunistically buying back our stock."

\*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company's control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes.

**Conference Call and Webcast Information**

The Company has also scheduled a conference call for Friday, March 10, 2023 at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex's website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link: https://register.vevent.com/register/BIc7e66b8a6c024100847adde656098b34

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company's website at http://www.quanex.com in the Investors section under Presentations & Events.

**About Quanex** 

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, vinyl fencing, solar, refrigeration and cabinetry markets. Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

For more information contact Scott Zuehlke, Senior Vice President, Chief Financial Officer & Treasurer, at 713-877-5327 or scott.zuehlke@quanex.com.

**Non-GAAP Terminology Definitions and Disclaimers**

Adjusted Net Income (defined as net income further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges, asset impairment charges, other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net) and Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making. Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex's leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company's credit agreement. Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making. Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company's residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company's financial and cash management performance. Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company's financial performance when comparing results to other investment opportunities. The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

**Forward Looking Statements**

Statements that use the words "estimated," "expect," "could," "should," "believe," "will," "might," or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: impacts from public health issues (including pandemics, such as the recent COVID-19 pandemic) on the economy and the demand for Quanex's products, the Company's future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to Quanex's industry, and the Company's future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. For a complete discussion of factors that may affect Quanex's future performance, please refer to the Company's Annual Report on Form 10-K for the fiscal year ended October 31, 2022, and the Company's Quarterly Reports on Form 10-Q under the sections entitled "Cautionary Note Regarding Forward-Looking Statements" and "Risk Factors". Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.

**CONDENSED CONSOLIDATED STATEMENTS OF INCOME**

(In thousands, except per share data)

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended January 31,** | **Three Months Ended January 31,** |
|  | **2023** | **2022** |
| Net sales | $261916 | $267040 |
| Cost of sales | 210149 | 211834 |
| Selling, general and administrative | 36744 | 30823 |
| Depreciation and amortization | 10620 | 10257 |
| Operating income | 4403 | 14126 |
| Interest expense | (2259) | (523) |
| Other, net | 218 | 54 |
| Income before income taxes | 2362 | 13657 |
| Income tax expense | (453) | (2418) |
| Net income | $1909 | $11239 |
| Earnings per common share, basic | $0.06 | $0.34 |
| Earnings per common share, diluted | $0.06 | $0.34 |
| Weighted average common shares outstanding: |  |  |
| Basic | 32951 | 33124 |
| Diluted | 33137 | 33298 |
| Cash dividends per share | $0.08 | $0.08 |

---

**QUANEX BUILDING PRODUCTS CORPORATION**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

(In thousands)

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **January 31, 2023** | **October 31, 2022** |
| **ASSETS** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $43055 | $55093 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 84672 | 96018 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | 127735 | 120890 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid and other current assets | 11146 | 8664 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 266608 | 280665 |
| Property, plant and equipment, net | 242030 | 180400 |
| Operating lease right-of-use assets | 45996 | 56000 |
| Goodwill | 184706 | 137855 |
| Intangible assets, net | 83401 | 65035 |
| Other assets | 4285 | 4662 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $827026 | $724617 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $63093 | $77907 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 46064 | 52114 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | 1624 | 1049 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current maturities of long-term debt | 1996 | 1046 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current operating lease liabilities | 7213 | 7727 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 119990 | 139843 |
| Long-term debt | 151682 | 29628 |
| Noncurrent operating lease liabilities | 39725 | 49286 |
| Deferred pension benefits |  | 3917 |
| Deferred income taxes | 23249 | 22277 |
| Other liabilities | 16692 | 14831 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 351338 | 259782 |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock | 372 | 372 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in-capital | 249730 | 251947 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 336704 | 337456 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (38050) | (49422) |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock at cost | (73068) | (75518) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 475688 | 464835 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $827026 | $724617 |

---

**QUANEX BUILDING PRODUCTS CORPORATION**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW**

(In thousands)

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended January 31,** | **Three Months Ended January 31,** |
|  | **2023** | **2022** |
| **Operating activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $1909 | $11239 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 10620 | 10257 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 679 | 552 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax | 179 | 854 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | 1509 | 1218 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease in accounts receivable | 20502 | 8340 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease (increase) in inventory | 645 | (25318) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increase in other current assets | (1431) | (3534) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease in accounts payable | (21379) | (8391) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease in accrued liabilities | (12686) | (18248) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increase in income taxes payable | 536 | 1391 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in deferred pension benefits | 7 | (80) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increase in other long-term liabilities | 1461 | 404 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | 584 | (335) |
| Cash provided by (used for) operating activities | 3135 | (21651) |
| **Investing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business acquisition | (92000) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (7582) | (7370) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from disposition of capital assets | 98 | 10 |
| Cash used for investing activities | (99484) | (7360) |
| **Financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrowings under credit facilities | 102000 | 28000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayments of credit facility borrowings | (15000) | (3000) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayments of other long-term debt | (579) | (228) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock dividends paid | (2661) | (2587) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock | 99 | 55 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payroll tax paid to settle shares forfeited upon vesting of stock | (545) | (1383) |
| Cash used for financing activities | 83314 | 20857 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash provided by financing activities | 997 | (188) |
| Decrease in cash and cash equivalents | (12038) | (8342) |
| Cash and cash equivalents at beginning of period | 55093 | 40061 |
| Cash and cash equivalents at end of period | $43055 | $31719 |

---

**QUANEX BUILDING PRODUCTS CORPORATION**

**FREE CASH FLOW AND NET DEBT RECONCILIATION**

(In thousands)

(Unaudited)

---

| | | |
|:---|:---|:---|
| The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. | The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. | The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. |
|  | **Three Months Ended January 31,** | **Three Months Ended January 31,** |
|  | **2023** | **2022** |
| Cash provided by (used for) operating activities | $3135 | (21651) |
| Capital expenditures | (7582) | (7370) |
| **Free Cash Flow** | **($4447)** | **($29021)** |
| The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash. | The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash. | The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash. |
|  | **As of January 31,** | **As of January 31,** |
|  | **2023** | **2022** |
| Revolving credit facility | $100000 | $63000 |
| Finance lease obligations <sup>(1)</sup> | 55122 | 15048 |
| Total debt <sup>(2)</sup> | 155122 | 78048 |
| Less: Cash and cash equivalents | 43055 | 31719 |
| **Net Debt** | **$112067** | **$46329** |
| (1) Includes $53.2 million and $13.8 million in real estate lease liabilities considered finance leases under U.S. GAAP for the three months ended January 31, 2023 and January 31, 2022, respectively.. | (1) Includes $53.2 million and $13.8 million in real estate lease liabilities considered finance leases under U.S. GAAP for the three months ended January 31, 2023 and January 31, 2022, respectively.. | (1) Includes $53.2 million and $13.8 million in real estate lease liabilities considered finance leases under U.S. GAAP for the three months ended January 31, 2023 and January 31, 2022, respectively.. |
| (2) Excludes outstanding letters of credit. |  |  |

---

**QUANEX BUILDING PRODUCTS CORPORATION**

**NON-GAAP FINANCIAL MEASURE DISCLOSURE**

**LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION**

(In thousands, except per share data)

(Unaudited)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Reconciliation of Last Twelve Months Adjusted EBITDA** | **Three Months Ended**<br>**January 31, 2023** | **Three Months Ended**<br>**October 31, 2022** | **Three Months Ended**<br>**July 31, 2022** | **Three Months Ended**<br>**April 30, 2022** | **Total** |
|  | **Reconciliation** | **Reconciliation** | **Reconciliation** | **Reconciliation** | **Reconciliation** |
| Net income as reported | $1909 | $24667 | $25908 | $26522 | $79006 |
| Income tax expense | 453 | 3329 | 7801 | 7879 | 19462 |
| Other, net | (218) | (136) | (398) | (453) | (1205) |
| Interest expense | 2259 | 710 | 724 | 602 | 4295 |
| Depreciation and amortization | 10620 | 9555 | 9734 | 10563 | 40472 |
| EBITDA | 15023 | 38125 | 43769 | 45113 | 142030 |
| Selling, general and administrative<sup>(1)</sup> | 5448 | 564 | 419 | 131 | 6562 |
| Adjusted EBITDA | $20471 | $38689 | $44188 | $45244 | $148592 |
| (1) Transaction and advisory fees. | (1) Transaction and advisory fees. | (1) Transaction and advisory fees. | (1) Transaction and advisory fees. | (1) Transaction and advisory fees. | (1) Transaction and advisory fees. |

---

**QUANEX BUILDING PRODUCTS CORPORATION**

**NON-GAAP FINANCIAL MEASURE DISCLOSURE**

(In thousands, except per share data)

(Unaudited)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | | **Three Months Ended** | **Three Months Ended** | |
| **Reconciliation of Adjusted Net Income and Adjusted EPS** | **January 31, 2023** | **January 31, 2023** | | **January 31, 2022** | **January 31, 2022** | |
|  | **Net**<br>**Income** | **Diluted**<br>**EPS** | | **Net**<br>**Income** | **Diluted**<br>**EPS** | |
| Net income as reported | $1909 | $0.06 |  | $11239 | $0.34 |  |
| Net income reconciling items from below | 4154 | $0.12 |  | 33 | $- |  |
| Adjusted net income and adjusted EPS | $6063 | $0.18 |  | $11272 | $0.34 |  |
| **Reconciliation of Adjusted EBITDA** | **Three Months Ended**<br>**January 31, 2023** | **Three Months Ended**<br>**January 31, 2023** |  | **Three Months Ended**<br>**January 31, 2022** | **Three Months Ended**<br>**January 31, 2022** |  |
|  | **Reconciliation** |  |  | **Reconciliation** |  |  |
| Net income as reported | $1909 |  |  | $11239 |  |  |
| Income tax expense | 453 |  |  | 2418 |  |  |
| Other, net | (218) |  |  | (54) |  |  |
| Interest expense | 2259 |  |  | 523 |  |  |
| Depreciation and amortization | 10620 |  |  | 10257 |  |  |
| EBITDA | 15023 |  |  | 24383 |  |  |
| EBITDA reconciling items from below | 5448 |  |  | - |  |  |
| Adjusted EBITDA | $20471 |  |  | $24383 |  |  |
| **Reconciling Items** | **Three Months Ended**<br>**January 31, 2023** | **Three Months Ended**<br>**January 31, 2023** |  | **Three Months Ended**<br>**January 31, 2022** | **Three Months Ended**<br>**January 31, 2022** |  |
|  | **Income**<br>**Statement** | **Reconciling**<br>**Items** |  | **Income**<br>**Statement** | **Reconciling**<br>**Items** |  |
| Net sales | $261916 | $- |  | $267040 | $- |  |
| Cost of sales | 210149 |  |  | 211834 |  |  |
| Selling, general and administrative | 36744 | (5448) | *(1)* | 30823 |  |  |
| EBITDA | 15023 | 5448 |  | 24383 |  |  |
| Depreciation and amortization | 10620 | - |  | 10257 | - |  |
| Operating income | 4403 | 5448 |  | 14126 |  |  |
| Interest expense | (2259) |  |  | (523) |  |  |
| Other, net | 218 | (42) | *(2)* | 54 | 41 | *(2)* |
| Income before income taxes | 2362 | 5406 |  | 13657 | 41 |  |
| Income tax expense | (453) | (1252) | *(3)* | (2418) | (8) | *(3)* |
| Net income | $1909 | $4154 |  | $11239 | $33 |  |
| Diluted earnings per share | $0.06 |  |  | $0.34 |  |  |
| (1) Transaction and advisory fees. | (1) Transaction and advisory fees. | (1) Transaction and advisory fees. | (1) Transaction and advisory fees. | (1) Transaction and advisory fees. | (1) Transaction and advisory fees. |  |
| (2) Foreign currency transaction (gains) losses. | (2) Foreign currency transaction (gains) losses. | (2) Foreign currency transaction (gains) losses. | (2) Foreign currency transaction (gains) losses. | (2) Foreign currency transaction (gains) losses. | (2) Foreign currency transaction (gains) losses. |  |
| (3) Impact on a with and without basis. |  |  |  |  |  |  |

---

**QUANEX BUILDING PRODUCTS CORPORATION**

**SELECTED SEGMENT DATA**

(In thousands)

(Unaudited)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| This table provides gross margin, operating (loss) income, EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. | This table provides gross margin, operating (loss) income, EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. | This table provides gross margin, operating (loss) income, EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. | This table provides gross margin, operating (loss) income, EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. | This table provides gross margin, operating (loss) income, EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. | This table provides gross margin, operating (loss) income, EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. |
|  | **NA Fenestration** | **EU Fenestration** | **NA Cabinet<br>Components** | **Unallocated**<br>**Corp & Other** | **Total** |
| **Three months ended January 31, 2023** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $152980 | $54952 | $54674 | $(690) | $261916 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 124717 | 37703 | 48056 | (327) | 210149 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross Margin | 28263 | 17249 | 6618 | (363) | 51767 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Gross Margin %* | *18.5 %* | *31.4 %* | *12.1 %* |  | *19.8 %* |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 13295 | 7505 | 4873 | 11071 | 36744 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 5245 | 2348 | 2934 | 93 | 10620 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income (loss) | 9723 | 7396 | (1189) | (11527) | 4403 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 5245 | 2348 | 2934 | 93 | 10620 |
| &nbsp;&nbsp;&nbsp;&nbsp;EBITDA | 14968 | 9744 | 1745 | (11434) | 15023 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transaction and advisory fees | - | - | - | 5448 | 5448 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | $14968 | $9744 | $1745 | $(5986) | $20471 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Adjusted EBITDA Margin %* | *9.8 %* | *17.7 %* | *3.2 %* |  | *7.8 %* |
| **Three months ended January 31, 2022** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $146631 | $58914 | $62353 | $(858) | $267040 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 115964 | 41227 | 55073 | (430) | 211834 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross Margin | 30667 | 17687 | 7280 | (428) | 55206 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Gross Margin %* | *20.9 %* | *30.0 %* | *11.7 %* |  | *20.7 %* |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 14377 | 7303 | 5270 | 3873 | 30823 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 4139 | 2569 | 3463 | 86 | 10257 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income (loss) | 12151 | 7815 | (1453) | (4387) | 14126 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 4139 | 2569 | 3463 | 86 | 10257 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EBITDA | 16290 | 10384 | 2010 | (4301) | 24383 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | $16290 | $10384 | $2010 | $(4301) | $24383 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*Adjusted EBITDA Margin %* | *11.1 %* | *17.6 %* | *3.2 %* |  | *9.1 %* |

---

**QUANEX BUILDING PRODUCTS CORPORATION**

**SALES ANALYSIS**

(In thousands)

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **<u>Three Months Ended January 31,</u>** | **<u>Three Months Ended January 31,</u>** |
|  | **<u>2023</u>** | **<u>2022</u>** |
| **NA Fenestration:** |  |  |
| United States - fenestration | $120767 | $128367 |
| International - fenestration | 5127 | 9136 |
| United States - non-fenestration | 23066 | 6716 |
| International - non-fenestration | 4020 | 2412 |
|  | $152980 | $146631 |
| **EU Fenestration:<sup>(1)</sup>** |  |  |
| International - fenestration | $42354 | $44621 |
| International - non-fenestration | 12598 | 14293 |
|  | $54952 | $58914 |
| **NA Cabinet Components:** |  |  |
| United States - fenestration | $3908 | $3765 |
| United States - non-fenestration | 50049 | 57767 |
| International - non-fenestration | 717 | 821 |
|  | $54674 | $62353 |
| **Unallocated Corporate & Other:** |  |  |
| Eliminations | $(690) | $(858) |
|  | $(690) | $(858) |
| **Net Sales** | $261916 | $267040 |
| (1) Reflects a reduction of $6.0 million in revenue associated with foreign currency exchange rate impacts for the three months ended January 31, 2023. | (1) Reflects a reduction of $6.0 million in revenue associated with foreign currency exchange rate impacts for the three months ended January 31, 2023. | (1) Reflects a reduction of $6.0 million in revenue associated with foreign currency exchange rate impacts for the three months ended January 31, 2023. |

---